Introduction
In eukaryotic cells, maturation-or M-phase promoting factor (MPF) controls both entry into and exit from M-phase (reviewed in Nigg, 2001 ). The major component of MPF is an active complex of the catalytic Cdc2 with the regulatory cyclin B. The activity of cyclin B±Cdc2 kinase is regulated not only by the formation of the complex but also by phosphorylation/dephosphorylation of the Cdc2 subunit (reviewed in Coleman and Dunphy, 1994; Lew and Kornbluth, 1996; O'Farrell, 2001) . Cyclin B-associated Cdc2 undergoes inhibitory phosphorylation at Thr14 and Tyr15 by the Wee1 family of protein kinases (Wee1, Mik1 and Myt1) during interphase, and at entry into M-phase, the inhibitory phosphates are removed by the activating phosphatase Cdc25C. The initial activation of cyclin B±Cdc2 appears to be triggered by a reversal of the balance between the opposing Wee1 family kinases and Cdc25C phosphatase. Logically, upon entry into M-phase, inactivation of the Wee1 family and/or activation of Cdc25C should occur prior to the initial activation of cyclin B±Cdc2, though thereafter the active cyclin B±Cdc2 can itself phosphorylate both Wee1 and Cdc25C to create positive feedback loops.
Both Wee1 family kinases and Cdc25C can be phosphorylated in vivo in the absence of cyclin B±Cdc2 kinase activity (Izumi and Maller, 1995; Mueller et al., 1995; Okumura et al., 1996; Okumura et al., 2002) . Accordingly, a trigger kinase(s) has been postulated to be responsible for inactivation of the Wee1 family and/or activation of Cdc25C prior to cyclin B±Cdc2 activation. In vitro, the kinases p90 rsk and calcium/calmodulin-dependent protein kinase (CaM kinase II) can phosphorylate and regulate either Myt1 or Cdc25C (Palmer et al., 1998; Patel et al., 1999) , but it remains unclear whether they function as trigger kinases in vivo. Plx1, the Xenopus homolog of the Polo-like kinase 1 (Plk1), has also been identi®ed as a kinase that can phosphorylate and activate Cdc25C in vitro (Kumagai and Dunphy, 1996) . Plk1 is conserved among various organisms and is implicated in multiple stages of M-phase progression (reviewed in Glover et al., 1998; Nigg, 1998 Nigg, , 2001 ). Plk1 has been proposed as a candidate for the trigger kinase that initiates the activation of cyclin B±Cdc2 via activation of Cdc25C (see Lane and Nigg, 1997) , but other studies have shown that Plk1 is a component of the positive feedback loop rather than an initial activator of cyclin B±Cdc2 (Abrieu et al., 1998; Karaiskou et al., 1998; Qian et al., 1998a) . Thus, further clari®cation is needed as to whether Plk1 is the actual trigger kinase.
Plk1 protein levels peak at M-phase in the somatic cell cycle, while they remain constant through meiotic and early embryonic cycles (Golsteyn et al., 1995; Hamanaka et al., 1995; Qian et al., 1998a; Pahlavan et al., 2000) . In both cases, Plk1 is phosphorylated during the G 2 /M-phase transition and shows high activity during M-phase. xPlkk1 and Ste20-like kinase have been identi®ed as direct activators of Plk1 in Xenopus oocytes (Qian et al., 1998b) and somatic cells (Ellinger-Ziegelbauer et al., 2000) , respectively. In addition, involvement of other kinases, including cyclin B±Cdc2, has been suggested for Plk1 activation (Kelm et al., 2002) . If Plk1 functions as the trigger kinase, molecule(s) other than cyclin B±Cdc2 should cause the initial activation of Plk1. Thus, the upstream regulator(s) of Plk1 remains unclear.
Most recently we have demonstrated that the kinase Akt/PKB, a transducer of multiple cellular signals (reviewed in Brazil and Hemmings, 2001) , functions as the trigger kinase through direct phosphorylation and inhibition of Myt1 at the meiotic G 2 /M-phase transition in star®sh oocytes (Okumura et al., 2002) . This has prompted us to reconsider the putative role of Plk1 as the trigger kinase, and to search for upstream regulators of Plk1, if it functions as the trigger kinase.
Fully grown immature oocytes of the star®sh are arrested at prophase of meiosis I and already contain inactive cyclin B±Cdc2 (Okano-Uchida et al., 1998; reviewed in Kishimoto, 1998) . The release from the prophase arrest is equivalent to the G 2 /M-phase transition and is induced by an extracellular hormonal stimulus with no requirement for new protein synthesis. Once meiosis is reinitiated, star®sh oocytes proceed completely through meiosis I and II, and in the absence of fertilization, arrest in interphase as haploid eggs. Upon fertilization, these eggs undergo embryonic mitotic cycles. In the present study, using a speci®c antibody which prevents the activation of Plk1 in star®sh oocytes and eggs, we have examined the involvement of Plk1 in the activation of cyclin B±Cdc2 during meiotic and early cleavage cycles. Our results show that distinct kinases, cyclin B±Cdc2, MAP kinase (MAPK) along with Cdc2 (either with cyclin A or cyclin B) and cyclin A±Cdc2, are upstream regulators for Plk1 activation at meiosis I, meiosis II and early embryonic M-phase, respectively, indicating that Plk1 does not function as a trigger kinase at meiosis I. We have also identi®ed Myt1, rather than Cdc25, as the mediator of Plk1-dependent activation of cyclin B±Cdc2.
Results
Isolation of star®sh Plk1 and Wee1 cDNAs, and characterization of antibodies To examine whether and how Plk1 is involved in cyclin B± Cdc2 activation in star®sh meiotic and cleavage cycles, we isolated cDNAs of the star®sh homologs of Plk1 and Wee1 (DDBJ/EMBL/GenBank accession no. AB084465 for Plk1, and no. AB064523 for Wee1). These encoded 623 amino acids with the predicted molecular weight of 71.0 kDa for Plk1, and 623 amino acids with 69.9 kDa for Wee1 (Supplementary ®gure 1A and B, available at The EMBO Journal Online). Star®sh Plk1 contained the characteristic polo-box (amino acids 414±443) and the amino acid sequence was 51% identical to that of mammalian Plk1s. Star®sh Wee1 was 38% identical to sea urchin Wee1 and 28% identical to vertebrate Wee1s.
An af®nity-puri®ed anti-Plk1 antibody recognized a single band of 67 kDa in lysates of immature star®sh oocytes (Figure 1, lanes 1 and 3) . A slightly slowermigrating band was observed in maturing oocytes at metaphase of meiosis I (Figure 1, lane 2) , suggesting phosphorylation at M-phase. An af®nity-puri®ed antiWee1 antibody speci®cally recognized star®sh Wee1. Wee1 protein was undetectable in immature oocytes and during meiosis I (Figure 1 , lanes 4 and 5; see Figures 8B and 9C) as in Xenopus oocytes (Murakami and Vande Woude, 1998; Iwabuchi et al., 2000) . The levels of Wee1 protein gradually increased after meiosis I and remained almost constant through cleavage cycles. Wee1 underwent maximal phosphorylation at each M-phase of cleavage cycles (Figure 1, lanes 6 and 7; see Figures 8B and 9C) .
Dynamics of Plk1 during meiotic and early cleavage cycles
Plk1 protein was present in immature oocytes, and its protein levels remained constant throughout star®sh meiotic and cleavage cycles, independent of new protein synthesis (Figure 2 , upper and data not shown). Plk1 activity measured in anti-Plk1 immunoprecipitates was very low in immature oocytes and increased before germinal vesicle breakdown (GVBD), almost simultaneously with the activation of cyclin B±Cdc2 but earlier than that of MAPK. Plk1 activity was maintained at signi®cantly elevated levels until and after the completion of meiosis II unless fertilization occurred, though it slightly decreased after GVBD and¯uctuated along with the meiotic cycles (Figure 2 ). When maturing star®sh oocytes were inseminated at meiosis I, and proceeded into 3 and 4) , oocytes at metaphase of meiosis I (lanes 2 and 5), unfertilized mature eggs (lane 6) and eggs at metaphase of the ®rst cleavage cycle (lane 7) were separated on a 10% SDS±PAGE gel and blotted onto nitrocellulose. Each blot was probed with af®nity-puri®ed anti-Plk1 antibody (lanes 1±3) and anti-Wee1 antibody (lanes 4±7). Molecular weight markers are indicated in kDa. Fig. 2 . Dynamics of Plk1 protein levels and kinase activity during star®sh meiotic and cleavage cycles. Extracts were prepared from unfertilized (A) or fertilized (B) oocytes and eggs at 10 min intervals after 1-MeAde addition, and immunoblotted with anti-Plk1 (upper) and anti-MAPK (B, lowest) antibodies. Immunoprecipitates with the antiPlk1 antibody were assayed for phosphorylation of a-casein (middle). Extracts were also assayed for phosphorylation of histone H1 (lower). Arrows indicate the time of GVBD, the ®rst (1PB) and second (2PB) polar body emission, and the ®rst (1CL) and second (2CL) cleavage. The arrowhead, the time of insemination.
cleavage cycles after the completion of meiosis II, Plk1 activity was almost lost following the inactivation of MAPK and H1 kinase at the completion of meiosis II, and thereafter¯uctuated along with cleavage cycles peaking at each M-phase but with a lag behind H1 kinase activity ( Figure 2B ).
Plk1 activation depends on cyclin B±Cdc2 activation at reinitiation of meiosis I Precise monitoring of the kinetics after hormone addition revealed that the activation of cyclin B±Cdc2 slightly preceded that of Plk1 at meiotic reinitiation ( Figure 3A , compare at 6 and 9 min). To examine whether the activation of cyclin B±Cdc2 is required for that of Plk1, we used an anti-star®sh Cdc25 antibody, which neutralizes Cdc25 phosphatase activity and hence suppresses cyclin B±Cdc2 activation in vivo (Okumura et al., 1996) . Injection of the anti±Cdc25 antibody into immature oocytes completely suppressed the activation of not only cyclin B±Cdc2 but also Plk1 after hormonal stimulus ( Figure 3B , +anti-Cdc25). Further, the initial phosphorylation of Cdc25 occurred in the absence of activation both of cyclin B±Cdc2 and Plk1 ( Figure 3B , lower). Similar inhibition of Plk1 activation along with the initial phosphorylation of Cdc25 was observed when p13 suc1 was used to suppress cyclin B±Cdc2 activation ( Figure 3B , +p13 suc1 ). Thus, at reinitiation of meiosis I, Plk1 activation depends on cyclin B±Cdc2 activation, excluding the possibility that Plk1 triggers the activation of Cdc25 prior to cyclin B±Cdc2 activation.
Plk1 activity is required neither for reinitiation of nor for exit from meiosis I, but is required for the formation of a bipolar metaphase I spindle To con®rm that Plk1 is not the trigger kinase for cyclin B± Cdc2 activation at meiotic reinitiation, we examined the effect of prevention of Plk1 activation. While Plk1 activity was detectable in anti-Plk1 immunoprecipitates from Fig. 3 . Suppression of H1 kinase activation prevents Plk1 activation at reinitiation of meiosis I. (A) Extracts were prepared at 3 min intervals after 1-MeAde addition, and Plk1 (upper) and histone H1 kinase (lower) activities were assayed as in Figure 2. (B) Immature oocytes were uninjected (control) or injected with either neutralizing antiCdc25 antibody (+anti-Cdc25) or p13 suc1 protein (+p13 suc1 ), and then treated with 1-MeAde. Extracts were prepared from groups of 10 oocytes at 10 min intervals, and histone H1 kinase (upper) and Plk1 (middle) activities were determined. Phosphorylation states of Cdc25 were analyzed by immunoblots with the anti-Cdc25 antibody (lower). Plk1 and cyclin B±Cdc2 activation oocytes undergoing GVBD (see above), it was almost undetectable in those from oocytes undergoing GVBD into which the same anti-Plk1 antibody had been injected prior to hormone addition ( Figure 4A ), indicating that the antiPlk1 antibody prevented the activation of Plk1 in vivo. In oocytes lacking Plk1 activation, full activation of cyclin B± Cdc2 and GVBD both occurred normally with only a slight delay ( Figure 4B and C) and Cdc25 was fully phosphorylated in metaphase I (see Figure 5C , 45 min). Thus, at reinitiation of meiosis I, Plk1 is neither required for initial activation of cyclin B±Cdc2, nor essential for full activation of both Cdc25 and cyclin B±Cdc2. Further, Plk1 is not required for MAPK activation at meiotic reinitiation (see Figure 5C , 45 min).
To test another possible role for Plk1 at meiosis I, we examined spindle formation, which is a conserved function for Plk1s in many species (reviewed in Glover et al., 1998; Nigg, 1998) . Anti-Plk1 antibody injection resulted in a monopolar spindle with an altered pattern of b-tubulin and a radial distribution of chromosomes around the pole, while in control IgG-injected oocytes, a normal bipolar spindle was formed at metaphase of meiosis I ( Figure 4D ). These observations demonstrate that in meiosis I of star®sh oocytes, Plk1 activity is required for meiotic spindle formation.
We next examined the role of Plk1 on the dynamics of cyclin B±Cdc2 during exit from meiosis I. In the anti-Plk1 antibody-injected oocytes, inactivation of cyclin B±Cdc2 and cyclin B destruction occurred with almost normal kinetics ( Figure 5A , middle and 5B, upper). The observed slight delay may re¯ect that in the activation of cyclin B± Cdc2 (see Figure 4B ). Thus, Plk1 activity is dispensable for cyclin B destruction at the end of meiosis I. These observations are in agreement with a report in Drosophila spermatocytes (Carmena et al., 1998) , but contrast with other reports that Plk1 is involved in the activation of the cyclin B destruction machinery (reviewed in Glover et al., 1998; Nigg, 1998 Nigg, , 2001 ).
Plk1 is required for activation of cyclin B±Cdc2 at entry into meiosis II through suppression of Myt1
In oocytes lacking Plk1 activity due to antibody injection, cyclin B±Cdc2 failed to be reactivated after exit from meiosis I, despite a normal reaccumulation of cyclin B after its destruction ( Figure 5A , middle and 5B, upper; compare 70 min in control with 80 min in +anti-Plk1). Instead, the lack of cyclin B±Cdc2 reactivation appeared to be due to inhibitory phosphorylation of Cdc2, that was not observed at the normal meiosis I to II transition ( Figure 5B, lower; compare 60 and 70 min in control with 70 and 80 min in +anti-Plk1). Thus, Plk1 is likely to be required for rapid activation of cyclin B±Cdc2 at entry into meiosis II through preventing inhibitory phosphorylation of Cdc2. This requirement of Plk1 is consistent with the presence of signi®cant levels of Plk1 activity during the meiosis I to II transition (see Figure 2) .
In contrast to cyclin B, cyclin A±Cdc2 was activated with normal timing after meiosis I even in the absence of Plk1 activity ( Figure 5A , lower), indicating that cyclin A± Cdc2 is activated independently of Plk1 and cyclin B± Cdc2 activities. This may be explained by the fact that cyclin A-associated Cdc2 does not undergo inhibitory phosphorylation during meiotic and cleavage cycles (Okano-Uchida et al., 1998) . Thereafter, cyclin A±Cdc2 activity was augmented possibly due to the lack of cyclin A destruction.
To investigate how the absence of Plk1 activity causes inhibitory phosphorylation of cyclin B-associated Cdc2, we examined the state of kinases responsible for the phosphorylation. Since Wee1 protein levels were low at the end of meiosis I, it is unlikely that Wee1 contributes signi®cantly to inhibitory phosphorylation of Cdc2. On the other hand, Myt1 protein, which was present at constant levels through meiotic and cleavage cycles (see Figures 8B  and 9B ), became severely, though not completely, dephosphorylated after exit from meiosis I in oocytes lacking Plk1 (and cyclin B±Cdc2 but not cyclin A±Cdc2) activity ( Figure 5C , 80 min). In contrast, in oocytes in which Plk1 (and cyclin A±Cdc2 but not cyclin B±Cdc2) was active, Myt1 was only slightly dephosphorylated at exit from meiosis I and was still maintained in the highly phosphorylated state (see Figure 7A , +antisense cycB). These observations suggest that elevated Plk1 (but neither cyclin A±Cdc2 nor cyclin B±Cdc2) activity is involved in maintenance of phosphorylated and most possibly suppressed states of Myt1 to cause the rapid activation of cyclin B±Cdc2 at entry into meiosis II. Both MAPK and Cdc2 are required to support Plk1 activity at meiosis II Since the c-Mos-MAPK pathway is required for occurrence of meiosis II in star®sh oocytes (Tachibana et al., 2000) , we examined whether MAPK contributes to the Plk1 activity during meiotic cycles. In the presence of an MEK inhibitor, U0126, MAPK activation after hormonal stimulus was completely prevented, whereas cyclin B± Cdc2 was activated normally and meiosis I resumed ( Figure 6A ). In these oocytes lacking MAPK activity, Plk1 activity increased normally but then declined at exit from meiosis I (Figure 6A, middle) . Conversely, in the absence of Plk1 activity, MAPK remained active after exit from meiosis I ( Figure 5C , 80 min; see also Figure 7A , +antisense cycA & B). These observations suggest that MAPK is involved in supporting the activity of Plk1 after meiosis I.
In the presence of MEK inhibitor, however, Plk1 was reactivated much later following the activation of cyclin A±Cdc2, but before that of cyclin B±Cdc2 ( Figure 6A , 90 min). This Plk1 activation is likely to re¯ect the situation of cleavage cycles (see below, cleavage cycles), since the prevention of the Mos-MAPK pathway causes mitotic cleavage cycles immediately after meiosis I (Tachibana et al., 2000) .
Precise examination of Figure 6A (MEK inhibitor, 50 and 60 min) indicated that the inactivation of cyclin B± Cdc2 preceded that of Plk1 at exit from meiosis I. In addition, protein synthesis was required for MAPK to support Plk1 activity after meiosis I (data not shown). These suggest the dependency of Plk1 activity on cyclin B± Cdc2 not only at meiotic reinitiation but also through meiotic cycles. Then, we prevented the activation of cyclin B±Cdc2 and/or cyclin A±Cdc2 after exit from meiosis I by inhibiting synthesis of cyclin B, cyclin A or both by use of morpholino or phosphorothioated antisense oligonucleotides ( Figure 7A ). In spite of the fact that MAPK remained active in all cases ( Figure 7A , +antisense cycA & B, lowest and data not shown), Plk1 remained active only in the presence of cyclin B±Cdc2 and/or cyclin A±Cdc2 activities, while if both activities were eliminated, Plk1 was inactivated after meiosis I. Thus, Cdc2 (either cyclin B±Cdc2 or cyclin A±Cdc2) activity is required for MAPK to support Plk1 activity at meiosis II. Consistently, activation of MAPK alone in immature star®sh oocytes failed to activate Plk1 and cyclin B±Cdc2 (data not shown; Tachibana et al., 2000) .
How then does MAPK, along with Cdc2, support Plk1 activity at meiosis II? Under conditions lacking cyclin B± Cdc2 but having cyclin A±Cdc2 activities, Plk1 was active only when MAPK was active (compare Figure 6 , MEK inhibitor with Figure 7A , +antisense cycB), indicating a pathway from MAPK to Plk1, but not through Cdc2. Another possible pathway would be from MAPK to the regulators of cyclin B±Cdc2 not via Plk1 and, as a result, would contribute to Plk1 activity. In fact, the phosphorylation states of Cdc25 showed little change in oocytes that were lacking in Plk1 (accordingly, cyclin B±Cdc2) activity but still had MAPK activity ( Figure 5C , 80 min), while the absence of MAPK activity caused dephosphorylation of Cdc25 after exit from meiosis I (even in the presence of cyclin A±Cdc2 activity) ( Figure 6B ; see ®gure 3C in Tachibana et al., 2000) . It is thus most likely that MAPK contributes, but not through Plk1, to the regulation of Cdc25 after meiosis I. Alternatively, immediately downstream of MAPK, p90 rsk is suggested to directly phosphorylate and down-regulate Myt1 in Xenopus oocytes (Palmer et al., 1998) . This pathway is apparently less likely, since even in the presence of MAPK activity, Myt1 was severely dephosphorylated when Plk1 and Cdc2 lost their activities ( Figure 5C , 80 min and Figure 7A , +antisense cycA & B). Nonetheless, considering that Myt1 was still slightly phosphorylated in this case, the pathway from MAPK to Myt1 not via Plk1 is not excluded during the meiosis I to II transition in star®sh oocytes as well.
Plk1 activation contributes to cyclin B±Cdc2 activation during cleavage cycles During cleavage cycles, the H1 kinase activity represents the total of the early activated cyclin A±Cdc2 and the late activated cyclin B±Cdc2 (Okano-Uchida et al., 1998) . Considering this, our observation that the activation of H1 kinase preceded that of Plk1 ( Figure 2B ) which was followed by that of cyclin B±Cdc2 ( Figure 9A , control) 
Plk1 and cyclin B±Cdc2 activation
indicates that ®rst cyclin A±Cdc2, then Plk1 and ®nally cyclin B±Cdc2, were activated during cleavage cycles. In agreement with this order, when activation of cyclin B± Cdc2 during the ®rst cleavage cycle was prevented by injecting neutralizing anti-Cdc25 antibody into female pronucleus stage eggs, activation of both Plk1 and cyclin A±Cdc2 occurred, although not to full levels ( Figure 7B ). Thus, in contrast to meiotic cycles, Plk1 activation does not depend on cyclin B±Cdc2 activity at entry into early embryonic M-phase.
Conversely, we examined whether Plk1 is required for cyclin B±Cdc2 activation during the ®rst cleavage cycle. The anti-Plk1 antibody was injected into mature eggs that had been previously inseminated during meiosis I and had just completed meiosis II as judged by emission of the second polar body. In the absence of Plk1 activation, the timing of cyclin B±Cdc2 activation associated with entry into the ®rst cleavage cycle was delayed by more than 30 min ( Figure 8A, middle) . In eggs lacking Plk1 activity, both accumulation of cyclin B and cyclin A proteins ( Figure 8B , upper) and activation of cyclin A±Cdc2 ( Figure 8A , lower) occurred normally. However, Cdc2, which might be associated with cyclin B, remained in the phosphorylated and thus inhibited state for a much longer period compared with control eggs ( Figure 8B , Cdc2, Uband). This indicated that, in the absence of Plk1 activity in the ®rst cleavage cycle, normal activation of cyclin B± Cdc2 did not occur, even though cyclin A±Cdc2 was activated normally. The delayed activation of cyclin B± Cdc2 may be ascribed to the hyperactivation of cyclin A± Cdc2 (see ®gure 8 in Okano-Uchida et al., 1998).
To examine why cyclin B±Cdc2 was not activated normally in the absence of Plk1 activity, we next investigated the phosphorylation states of Myt1 and Wee1. In control fertilized eggs, Myt1 showed only a slight dephosphorylation at the completion of meiosis II ( Figure 8B , Myt1, 90 min in control). In anti-Plk1 injected eggs, however, Myt1 was transiently dephosphorylated to a level comparable with that in immature oocytes ( Figure 8B , Myt1, 90 and 100 min in +anti-Plk1), whereas cyclin A±Cdc2 was activated ( Figure 8A, lower) . Conversely, Myt1 was phosphorylated even in the absence of cyclin B±Cdc2 activity when Plk1 was activated after fertilization ( Figure 7B ). In contrast, Wee1 was gradually phosphorylated prior to cyclin B±Cdc2 activation in control fertilized eggs ( Figures 8B and 9C , control in Wee1), and the prevention of Plk1 activation did not signi®cantly affect the Wee1 phosphorylation ( Figure 8B , +anti-Plk1 in Wee1). These observations suggest that during cleavage cycles Plk1 regulates the phosphorylation states (and most probably, the activity) of Myt1, but not of Wee1, and thus contributes to the normal activation of cyclin B±Cdc2.
Cyclin A±Cdc2 is required for both Plk1 activation and Wee1 phosphorylation during early cleavage cycles In the presence of the CDK inhibitor roscovitin, which inhibits both cyclin A±Cdc2 and cyclin B±Cdc2 activity, Plk1 activation in the ®rst cleavage cycle was prevented (data not shown). Considering that cyclin B±Cdc2 was not required for Plk1 activation ( Figure 7B ), it is plausible that cyclin A±Cdc2 contributes to Plk1 activation in the ®rst cleavage cycle. To examine this possibility, we used an antisense cyclin A oligonucleotide, which blocked the synthesis of cyclin A but not cyclin B (Figure 9, upper) . The antisense cyclin A oligonucleotide was injected into immature oocytes lacking cyclin A protein. It did not signi®cantly affect either reinitiation of meiosis I as judged by the occurrence of GVBD, or transition from meiosis I to II as judged by the kinetics of cyclin B±Cdc2 kinase activity (data not shown; see also Figure 7A , +antisense cycA). However, in the absence of cyclin A protein (i.e. cyclin A±Cdc2 activity), Plk1 activation after the decrease at the completion of meiosis II did not occur, though Plk1 protein was present ( Figure 9A, middle) . Under these conditions, cyclin B±Cdc2 also failed to be activated, and inhibitory phosphorylation of Cdc2 continued much longer than in control eggs ( Figure 9A , lower and 9C, middle). Although unusually delayed activation of Plk1 and cyclin B±Cdc2 was observed in the absence of cyclin A ( Figure 9A , 160 min and later), this may be related to unphysiological over-accumulation of cyclin B protein ( Figure 9A, upper) .
The defect in cyclin B±Cdc2 activation was more serious in cyclin A-de®cient eggs than in Plk1-de®cient eggs (compare Figure 9A with Figure 8A ), suggesting that in activating cyclin B±Cdc2, cyclin A±Cdc2 might have another role besides Plk1 activation. Myt1 was dephosphorylated after meiosis II in eggs lacking cyclin A protein, to a similar degree as in eggs lacking Plk1 activity (compare Figure 9B with Figure 8B ). In contrast, Wee1 phosphorylation, which occurred in eggs lacking Plk1 activity, was not observed in cyclin A-de®cient eggs (compare Figure 9C with Figure 8B ). Taken together, cyclin A±Cdc2 might contribute to cyclin B±Cdc2 activation during cleavage cycles through two separate pathways, Plk1 activation and Wee1 phosphorylation.
Discussion
The present study on the interrelations among Plk1, cyclin B±Cdc2, cyclin A±Cdc2 and MAPK through star®sh meiotic and early embryonic cycles has revealed that upstream regulators of Plk1 are cyclin B±Cdc2 at reinitiation of meiosis I, MAPK along with Cdc2 at entry into meiosis II and cyclin A±Cdc2 at entry into embryonic M-phase (Figure 10 ). These imply that Plk1 functions as a trigger kinase for the initial activation of cyclin B±Cdc2 in mitotic cleavage cycles, but not in meiosis I.
Target of Plk1 in triggering cyclin B±Cdc2 activation
The idea that Plk1 is a trigger kinase for Cdc25C activation (reviewed in Lane and Nigg, 1997) arose primarily from Plk1 and cyclin B±Cdc2 activation two studies: identi®cation of Xenopus egg Plx1, which associates with and phosphorylates Cdc25C in vitro (Kumagai and Dunphy, 1996; Qian et al., 2001) , and the inhibitory effect of an anti-Plk1 antibody on entry into M-phase in non-immortalized Hs68 ®broblasts (Lane and Nigg, 1996) . This idea implies that Plk1 is initially activated and can phosphorylate/activate Cdc25C in the absence of cyclin B±Cdc2 activity. In a precise sense, however, no previous studies have examined this possibility (see Abrieu et al., 1998; Karaiskou et al., 1998; Qian et al., 1998a Qian et al., , 1999 Qian et al., , 2001 . Even though Plk1 functions as the trigger kinase for cyclin B±Cdc2 activation, it is still unclear whether the target of Plk1 is Cdc25C.
Unlike the case of meiosis I, our present observations of cleavage cycles agree with the proposed role of Plk1 as the trigger kinase for cyclin B±Cdc2 activation, but there is a substantial difference in the pathway from Plk1 to cyclin B±Cdc2. In contrast to the original proposal that Cdc25C is the direct target of Plk1, our present study revealed that lack of Plk1 activity has no signi®cant effect on the phosphorylation states of either Cdc25 or Wee1, but causes dephosphorylation of Myt1 ( Figures 5C, 7A and 8B). These observations suggest that independent of cyclin B±Cdc2 activity, Plk1 might regulate phosphorylation states and presumably activity of Myt1 at entry into M-phase. Consistently, hyperphosphorylation of Myt1 in Xenopus egg cycling extracts was strongly reduced when Plx1 activation was prevented (Abrieu et al., 1998) , but no other studies have examined Myt1 in relation to Plk1 (see Karaiskou et al., 1998; Qian et al., 1998a Qian et al., , 1999 Qian et al., , 2001 ). In our preliminary in vitro experiments, however, Plk1 phosphorylated but did not down-regulate Myt1 that was recovered from immature star®sh oocytes (data not shown). Nonetheless, it is possible that after meiosis I Plk1 directly down-regulates Myt1, because the phosphorylation state of Myt1 in immature oocytes is exceptionally low (see control in Figures 8B and 9B; Sillge and Nigg, 2003) .
Taken together, Myt1, rather than Cdc25C, might be the target of Plk1, when Plk1 functions at the initial step of cyclin B±Cdc2 activation (Figure 10 ). If Plk1 can affect the activity of cyclin B±Cdc2 via Myt1, then Cdc25C activity might be modi®ed by cyclin B±Cdc2. The direct phosphorylation of Cdc25C by Plk1, if it occurred, might affect the localization of Cdc25C (see ToyoshimaMorimoto et al., 2002) .
Interplay between Plk1 and Cdc2
The present observations in vivo are summarized as follows. (1) In meiosis I in which cyclin A is lacking, Plk1 activity is not required for cyclin B±Cdc2 activation and, conversely, Plk1 activation requires cyclin B±Cdc2 activity, indicating the pathway, cyclin B±Cdc2 ® Plk1. (2) In meiosis II in which MAPK is essential, Plk1 activity is required not for cyclin A±Cdc2 but for cyclin B±Cdc2 activation and, conversely, Plk1 activity requires either cyclin A±Cdc2 or cyclin B±Cdc2 activity along with MAPK activity, indicating the pathway, MAPK and cyclin A±Cdc2 ® Plk1 ¬® cyclin B±Cdc2. (3) In cleavage cycles, Plk1 activity is required not for cyclin A± Cdc2 but for cyclin B±Cdc2 activation and, conversely, Plk1 activation requires cyclin A±Cdc2 but not cyclin B± Cdc2 activity, indicating the pathway, cyclin A±Cdc2 ® Plk1 ® cyclin B±Cdc2 (Figure 10 ).
These three pathways may, at ®rst, appear to be somewhat confusing. However, considering that both cyclin A±Cdc2 and cyclin B±Cdc2 are able to cause activation of Plk1, we may assume that Plk1 does not strictly discriminate between cyclin A and cyclin B as its upstream regulator, apart from whether they can contribute equivalently. If so, one possible conclusion would be that Plk1 is always downstream of Cdc2. Consistently, in ®ssion yeast which has only one type of M-phase cyclin, Plo1/Plk does not function as the trigger kinase and rather, its activation depends on Cdc2 (Tanaka et al., 2001 ). Another conclusion would be that in general (i.e. in the mitotic cycle), cyclin A±Cdc2 triggers the activation of Plk1, which in turn triggers that of cyclin B±Cdc2, while modi®ed patterns occur in the meiotic cycle due to the absence of cyclin A at meiosis I and the presence of MAPK activity at meiosis II (see below). After these triggering steps, positive feedback loops involving Plk1, as reported previously (Abrieu et al., 1998; Karaiskou et al., 1998; Qian et al., 1998a) , might function to cause further and rapid activation of cyclin B±Cdc2.
How then does Cdc2 (with its A or B cyclin partner) cause the activation of Plk1? Plk1 is most likely activated by a homolog of xPlkk1 (Qian et al., 1998b) and it has been presumed that Cdc2 acts on a component upstream of the Plkk1±Plk1 pathway, because none of these is substrates for cyclin B±Cdc2 (Qian et al., 2001) . In contrast, Kelm et al. (2002) reported recently that Ser340 on Xenopus Plk1 is likely to be phosphorylated by cyclin B±Cdc2, though this site is not conserved in human and star®sh Plk1 (Supplementary ®gure 1A) . They also showed that Thr201, which is located within the Tloop and is highly conserved among various Plk1 including star®sh, is a major site of activation and phosphorylation, at least in vitro, by PKA or possibly by PDK1. In addition, the pathway from MAPK to Plk1 not via Cdc2 might be present (the present study at meiosis II). Thus, multiple kinases appear to be involved in the activation of Plk1, and the actions of Cdc2 on Plk1 require further study.
Plk1 in the regulation of meiotic and cleavage cycles Meiosis I. The present observations revealed that during meiosis I, Plk1 is required for bipolar spindle formation, but neither for the activation nor for the inactivation of cyclin B±Cdc2 (Figures 3±5). These are consistent with the original ®nding that Polo was identi®ed in Drosophila as a gene required for formation of the bipolar spindle (Sunkel and Glover, 1988) and support that a conserved role for Plk1 among many eukaryotic cells (except for budding yeast) is to form the bipolar spindle.
If Plk1 is always downstream of Cdc2 (see above), Plk1 activation in meiosis I is most likely to rely on cyclin B± Cdc2 due to the absence of cyclin A. This implies that in meiosis I, cyclin B±Cdc2 should be initially activated independently of Plk1 and hence Plk1 does not function as the trigger kinase. Consistently, in the case of star®sh oocytes, cyclin B±Cdc2 is activated initially through a signaling pathway in which Akt/PKB is the trigger kinase (Okumura et al., 2002) . It has been suggested in Xenopus and mouse oocytes also that Plk1 activation requires prior activation of cyclin B±Cdc2 (Karaiskou et al., 1998; Qian et al., 1998a; Pahlavan et al., 2000) , though it is still uncertain whether inhibition of cyclin B±Cdc2 activation prevents Plk1 activation at meiotic reinitiation in these oocytes. Meiosis I to II transition. The present observations indicate that only at meiosis II, Plk1 activity relies on MAPK in addition to Cdc2 (Figures 6 and 7A) . Why is MAPK required? What is essential for the successful transition from meiosis I to II is that after exit from meiosis I, cyclin B±Cdc2 is reactivated bypassing inhibitory phosphorylation of Cdc2 (see Iwabuchi et al., 2000; Tachibana et al., 2000) . Although cyclin A±Cdc2 is activated at entry into both meiosis II and embryonic M-phase, the activation of cyclin A±Cdc2 alone results in the process of inhibitory phosphorylation of cyclin B-associated Cdc2 even if cyclin B±Cdc2 is ®nally activated (compare meiosis II with cleavage cycle). This implies that cyclin A alone is not suf®cient and MAPK supplements cyclin A for the rapid activation of cyclin B±Cdc2 at entry into meiosis II. The presence of various pathways for such an effect of MAPK was suggested in the present observations: a positive one from MAPK to Plk1, a positive one from MAPK to Cdc25, a possible negative one from MAPK to Myt1, and a negative one from Plk1 to Myt1 (Figures 5, 6, 7A and 10) . In addition, at the exit from meiosis I, MAPK might to some extent support cyclin B± Cdc2 activity, which in turn contributes to Plk1 activity at entry into meiosis II ( Figure 7A , +antisense A), since cyclin B±Cdc2 was inactivated at exit from meiosis I signi®cantly earlier in the absence of MAPK activity than in its presence ( Figure 6A , compare at 50 and 60 min; see also Picard et al., 1996) .
Taken together, although the Mos-MAPK pathway governs the meiosis I to II transition, Plk1 is demonstrated to play an indispensable role in mediating the action of MAPK. M-phase entry in cleavage cycles. In contrast to the meiotic cycles, early embryonic cycles clearly required cyclin A±Cdc2 for Plk1 activation ( Figure 9A ). Cyclin A± Cdc2 has long been suggested to play an important role at the G 2 /M-phase transition (for example, Lehner and O'Farrell, 1990; Devault et al., 1992; Pagano et al., 1992) , whereas its target remains unclear. Our results provide a possible answer to this question: cyclin A±Cdc2, which is active prior to cyclin B±Cdc2, contributes to both Plk1-dependent hyperphosphorylation of Myt1 and Plk1-independent phosphorylation of Wee1, and thereby to cyclin B±Cdc2 activation (Figure 10 ).
Materials and methods

Preparation of oocyte and egg extracts
Oocytes of the star®sh, Asterina pectinifera, and their extracts were prepared essentially as described previously (Okano-Uchida et al., 1998) . See Supplementary data for details.
Isolation and sequencing of star®sh Plk1 and Wee1 cDNAs Star®sh homologs of Plk1 and Wee1 cDNAs were isolated by RT±PCR, and 5¢ and 3¢ RACE. See Supplementary data for details.
Antibodies
The rabbit polyclonal antibodies were raised against star®sh Plk1 (amino acids 30±431) and Wee1 (amino acids 301±413) and were af®nity puri®ed. See Supplementary data for details.
Microinjection
Microinjection was performed according as described previously (Kishimoto, 1986) . Immature oocytes were injected with 0.2 mg/ml of anti-star®sh Cdc25 antibody (20 pg/oocyte), 1.5 mg/ml of af®nity-puri®ed anti-star®sh Plk1 antibody (300 pg/oocyte), 13 mg/ml of p13 suc1 protein (1 ng/oocyte), cyclin B morpholino oligo (ATTGTAACCA-ATGCGAGTTCTGAGG; ®nal concentration 3 mM) or cyclin A antisense S-oligo (5¢-GGACATGTTGAGTGTTC-3¢ corresponding to the translation initiation site, nucleotides 101±117; ®nal concentration 3 mM), and then treated with 1-MeAde.
Immunoblotting
Samples were separated on 10% polyacrylamide gels and immunoblotting was performed essentially as described previously (OkanoUchida et al., 1998) . To resolve inhibitory phosphorylation of Cdc2, a modi®ed electrode buffer (75 mM Tris, 450 mM glycine, 0.1% SDS) was used. See Supplementary data for details.
Immunoprecipitation and kinase assays
For histone H1 kinase assays, 1 ml extracts equivalent to half of an oocyte were diluted into 4 ml kinase buffer (80 mM Na-b-glycerophosphate, 20 mM EGTA, 15 mM MgCl 2 , 1 mM DTT, pH 7.3), then incubated for 15 min at 25°C in a ®nal volume of 10 ml containing 0.3 mg/ml histone H1 (Boehringer), and 0.2 mCi/ml [g-32 P]ATP (Amersham Pharmacia Biotech). For individual kinase assays of cyclin B±Cdc2 or cyclin A± Cdc2, extracts equivalent to one oocyte were incubated with protein A Sepharose CL-4B conjugated with anti-cyclin B or anti-cyclin A antibody for 1 h at 4°C. Beads were washed three times with immunoprecipitation buffer (50 mM Tris±HCl pH 7.5, 150 mM NaCl, 25 mM NaF, 0.5% Nonidet P-40), twice with kinase buffer, and then suspended in 5 ml of kinase buffer. The kinase assay for anti-star®sh Plk1 immunoprecipitates was carried out for 45 min at 25°C using dephosphorylated a-casein (Sigma) as a substrate. The reaction was terminated by addition of 10 ml 23 SDS±PAGE sample buffer, followed by boiling for 5 min. Aliquots of Plk1 and cyclin B±Cdc2 activation 10 ml of samples were run on 12% SDS±PAGE and stained with 0.25% Coomassie Brilliant Blue R-250. The stained gels were autoradiographed with X-ray ®lm overnight at ±80°C.
Immuno¯uorescence
Immuno¯uorescence staining was performed according to Tachibana et al., 2000 . See Supplementary data for details.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
